Can We Change the Functionality of HDL Cholesterol with Nonpharmacological and Pharmacological Agents?

E-ISSN： 1875-533x|21|25|2927-2946

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.25, 2014-08, pp. : 2927-2946

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Pharmacological Treatments for Obesity

Child and Adolescent Psychopharmacology News, Vol. 15, Iss. 1, 2010-02 ,pp. : 7-9

Guilford Publications Inc

Access to resources Recommend Favorite

Pharmacological agents can ameliorate some of the neuropsychiatric adverse effects of interferon- treatment

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 11, 2005-11 ,pp. : 18-22

Adis International

Access to resources Recommend Favorite

Semisynthetic Hybrid Biopolymers for Non-pharmacological Intervention of the Microcirculation

Current Drug Metabolism, Vol. 14, Iss. 5, 2013-06 ,pp. : 540-546

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression

Current Pharmaceutical Design, Vol. 12, Iss. 4, 2006-02 ,pp. : 503-515

Bentham Science Publishers

Access to resources Recommend Favorite

A series of hydrazone derivatives that elevate HDL-cholesterol

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1293-1298

Informa Healthcare

Access to resources Recommend Favorite